WHO adds Roche’s arthritis drug tocilizumab to COVID-19 medicines list
WHO adds Roche’s arthritis drug tocilizumab to COVID-19 medicines list
February 11, 2022; 1:15 PM EST
GENEVA, Feb 11 (Reuters) – The World Health Organization said on Friday it had added its first monoclonal antibody tocilizumab to its so-called pre-qualification list, an official list of medicines used as a benchmark for procurement by developing countries.
The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann//File Photo
The WHO recommended the drug, manufactured by Roche and typically used to treat arthritis, only for patients diagnosed with severe or critical COVID-19.
Reporting by Emma Farge
Our Standards: The Thomson Reuters Trust Principles.
Reuters source:
